Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors

HIGHLIGHTS

• who: Richard Benjamin Young from the University of Kansas Medical Center, United States have published the research work: Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors, in the Journal: (JOURNAL) of January/26,/2022
• what: The study explored the clinical factors and predictive biomarkers that can be used to select cancer patients who may derive long term clinical benefit from ICI treatment during admission at an NCI designated comprehensive cancer center. The study demonstrates that a high comorbid burden (i.e., major organ dysfunction) and a . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.